Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
FATE
SCTX
Add up to 3 more stocks
FATE
Fate Therapeutics, Inc.
-5.14%
$2.31-0.13Delayed quote: Oct 6, 2026, 3:25 PM EDT
Market Cap
$268.67M
52W Range
$0.95 - $3.23
SCTX
Scribe Therapeutics Inc.
+1.08%
$16.39+0.18Delayed quote: Oct 6, 2026, 3:25 PM EDT
Market Cap
$265.14M
52W Range
$13.50 - $39.60
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.75 | N/A |
| P/S Ratio | 41.39 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -94.1% | N/A |
| Operating Margin | -2222.4% | N/A |
| Net Margin | -1941.1% | N/A |
| ROE | -82.1% | N/A |
| ROA | -48.4% | N/A |
| ROIC | -58.7% | N/A |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.85 | N/A |
| Quick Ratio | 4.85 | N/A |
| Debt/Equity | 0.49 | N/A |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.